Quartz 4

Research: Update Alibi Marketing with Indian Crackdown

7 min read

Research: Update Alibi Marketing with Indian Crackdown

Indian Regulatory Crackdown on Surrogate Advertising

The Indian regulatory framework governing the marketing of restricted products—primarily alcohol and tobacco—has undergone a significant paradigm shift. The historical reliance on voluntary codes to manage alibi-marketing and surrogate advertising is being replaced by statutory enforcement, primarily driven by the Central Consumer Protection Authority (CCPA) and the department-of-consumer-affairs-india. This regulatory evolution fundamentally alters how multinational beverage companies can execute master-brand-extensions-vs-new-to-world strategies in the Indian market.

Regulatory Evolution and Key Legislation

India’s historical approach to restricting alcohol and tobacco advertisements has been fragmented across multiple laws, including the Cable Television Networks (Regulation) Act, 1995, and the Cigarettes and Other Tobacco Products Act, 2003 (COTPA) [2, 4]. Because direct promotion is prohibited, beverage conglomerates heavily relied on surrogate advertising—using brand names of restricted products to sell ostensibly unrestricted products like club soda, bottled water, or music CDs (e.g., Bagpiper Club Soda or Bacardi’s NH7 Weekender sponsorships) [3, 10].

The regulatory landscape tightened significantly with the introduction of the Consumer Protection Act, 2019, and the subsequent “Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022” [1, 5]. Under this framework, the government formally defined surrogate advertising and shifted the issue from a purely broadcast regulation to a matter of consumer rights and protection [1, 5].

Anticipated sweeping updates to these rules are expected to implement a total ban on the use of alcohol and tobacco brand extensions that share characteristics with the core prohibited products, including logos, mascots, and color palettes [3, 6, 8].

Qualifying independent-existence-surrogate-advertising

To distinguish between a genuine brand extension and a surrogate advertisement, the advertising-standards-council-of-india-asci established stringent qualification criteria. These rules are designed to prevent the creation of “phantom” products whose sole purpose is to maintain visibility for the core alcohol or tobacco brand.

For an advertisement to be recognized as a legitimate brand extension rather than a surrogate, it must meet the following thresholds:

  • Registration: The product must be registered with an appropriate government authority such as the food-safety-and-standards-authority-of-india-fssai or the Trademark registry [9].
  • Sales Volume: For established brands (>2 years), the product must generate a national sales turnover exceeding ₹5 Crore (approx. $600,000 USD) annually, or ₹1 Crore per state of distribution. For newer products (<2 years), they must achieve a net sales turnover of at least ₹20 lakhs per month, or demonstrate fixed asset investments exclusive to the extension of not less than ₹10 Crore [7, 9].
  • Market Availability: In-store availability of the brand extension must be at least 10% of the leading brand within that specific product category [7].

The Advertising Budget Caps

To prevent companies from vastly outspending their extension’s actual commercial value to generate a halo-effect for the master brand, ASCI dictates that the advertising budget for the extension must be proportionate to its sales. The spending limits are capped at:

  • 200% of the sales turnover in Years 1 and 2 of the launch [9].
  • 100% in Year 3 [9].
  • 50% in Year 4, and 30% thereafter [9]. Furthermore, the introduction of mere “variants” (e.g., a new flavor of potato chips under an existing extension) does not reset the product’s launch date or allow for renewed budget limits [12].

Penalties and Celebrity Liability

The updated guidelines introduce severe statutory penalties for violations, aiming to make the fines outweigh the marketing benefits of non-compliance [8].

  • Financial Penalties: First-time offenses can attract fines of ₹10 lakh, escalating to ₹50 lakh (approx. $60,000 USD) for subsequent contraventions [1, 3].
  • Endorser Accountability: Celebrities and social media influencers (>500,000 followers or earning >₹40 lakhs) are now legally obligated to perform due diligence before endorsing a product [13, 14]. If found participating in deceptive surrogate advertising, promoters face endorsement bans ranging from one to three years [3, 6].

High-profile actors (such as Shah Rukh Khan, Akshay Kumar, and Ajay Devgn) have previously faced intense public and regulatory scrutiny for endorsing pan masala products (like Vimal Elaichi), widely considered surrogates for tobacco [3, 14]. The CCPA guidelines explicitly extend liability to these figures, effectively forcing celebrities and their management agencies to independently verify the legitimacy of the brand extensions they represent [13, 15].

Contradictions and Gaps in the Framework

While the ASCI guidelines and CCPA regulations are robust, industry analysts have noted strategic contradictions within the text:

  • The Celebrity Loophole: ASCI explicitly states that celebrity endorsement fees must be calculated within the capped advertising budget of a brand extension [9, 12]. Critics argue that by outlining how to financially account for celebrity payments, the guidelines inadvertently validate and permit the use of celebrities for restricted-brand extensions, which logically conflicts with other rules attempting to separate famous personalities from alcohol and tobacco marketing [12].
  • Enforcement Discrepancies: While national guidelines exist, the execution often conflicts with fragmented state-level excise laws. Alcohol remains a state-governed subject in India, leading to varying degrees of enforcement against event sponsorships and on-premise promotions [8].

Strategic Implications for the Beverage Industry

For major industry players, the era of treating surrogate marketing as a mere “marketing workaround” has ended. It is now classified as a high-risk commercial liability [5]. Regulators have already issued notices to multiple liquor brands for non-compliance, demanding proof of revenue models for their packaged water and music CD extensions [10]. Trade associations, such as the International Spirits and Wines Association of India (ISWAI), are actively lobbying to protect “genuine” brand extensions, recognizing that total bans on shared nomenclature will necessitate entirely bifurcated marketing divisions for alcohol and non-alcohol portfolios [6].

Suggested Additional Research

  • State-Level Excise Policies: Investigate the specific divergence between central CCPA advertising guidelines and individual state liquor marketing laws (e.g., Maharashtra vs. Delhi).
  • Trade Dress Litigation in India: Analyze how Indian courts evaluate identical color palettes and typographies when alcohol brands sponsor unrelated cultural events.

References

  • [1] Govt issues new guidelines to curb misleading ads; bans surrogate ads | India News - The Indian Express
  • [2] Surrogate Advertising in India: A critical Analysis - IJSDR
  • [3] Indian Govt plans new curbs on surrogate advertisements: Report
  • [4] Surrogate Advertisements: India’s Response Towards International
  • [5] Surrogate Advertising In India: Where Brand Strategy Meets Regulatory Risk - Broadcasting: Film, TV & Radio - India
  • [6] Alcohol advertising laws strengthened in India
  • [7] Indian Law on advertisement of brand extensions of alcohol and tobacco products and how it poised to become tougher – Arogya Legal
  • [8] Why India Must Close the Surrogate Advertising Loophole - EUCAM
  • [9] Guidelines for qualification of brand extension-product or service - ASCI
  • [10] Liquor brands get notices over surrogate advertising – EUCAM
  • [11] Surrogate advertising of intoxicating products: Self-regulatory nature of ASCI Code and challenge of covert ads
  • [12] Squeezing Surrogate Advertisements Further : ASCI Brings In Revised Guidelines - Tap-a-Gain
  • [13] Guidelines for celebrities in advertising - ASCI
  • [14] Unmasking Surrogate Advertising: Celebrities, Loopholes, and Battle for Ethical Visibility
  • [15] CCPA Guidelines On Misleading Advertisements And Endorsements – Quintess Law

References

  1. Govt issues new guidelines to curb misleading ads; bans surrogate ads | India News - The Indian Express — indianexpress.com
  2. [PDF] Surrogate Advertising in India: A critical Analysis - IJSDR — ijsdr.org
  3. Indian Govt plans new curbs on surrogate advertisements: Report — medianama.com
  4. [PDF] Surrogate Advertisements: India’s Response Towards International — manupatra.com
  5. Surrogate Advertising In India: Where Brand Strategy Meets Regulatory Risk - Broadcasting: Film, TV & Radio - India — mondaq.com
  6. Alcohol advertising laws strengthened in India — thedrinksbusiness.com
  7. Indian Law on advertisement of brand extensions of alcohol and tobacco products and how it poised to become tougher – Arogya Legal – The Health Laws Specialists — arogyalegal.com
  8. Why India Must Close the Surrogate Advertising Loophole - EUCAM — eucam.info
  9. [PDF] guidelines for qualification of brand extension-product or service — ascionline.in
  10. Liquor brands get notices over surrogate advertising – EUCAM — eucam.info
  11. Surrogate advertising of intoxicating products: Self-regulatory nature of ASCI Code and challenge of covert ads — barandbench.com
  12. Squeezing Surrogate Advertisements Further : ASCI Brings In Revised Guidelines - Tap-a-Gain — tap-a-gain.com
  13. [PDF] guidelines-for-celebrities-in-advertising.pdf - ASCI — ascionline.in
  14. Unmasking Surrogate Advertising: Celebrities, Loopholes, and Battle for Ethical Visibility — pitchonnet.com
  15. CCPA Guidelines On Misleading Advertisements And Endorsements – Quintess Law — quintesslaw.com

Graph View